Sana Biotechnology (SANA) Net Equity Issued and Repurchased (2020 - 2025)

Sana Biotechnology (SANA) has 5 years of Net Equity Issued and Repurchased data on file, last reported at $17.0 million in Q4 2025.

• For the quarter ending Q4 2025, Net Equity Issued and Repurchased changed N/A year-over-year to $17.0 million; the trailing twelve-month figure through Dec 2025 stood at $46.1 million (down 74.53% YoY), and the FY2025 full-year result was $126.4 million, down 30.16% from the prior year.
• Net Equity Issued and Repurchased slipped to $17.0 million in Q4 2025, from $28.6 million in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $152.3 million in Q2 2024 to a low of -$29000.0 in Q3 2024.
• A 4-year average of $18.5 million and a median of $1.4 million in 2022 frame the typical range for Net Equity Issued and Repurchased.
• Across the five-year window, Net Equity Issued and Repurchased sank 115.1% in 2024 and jumped 98720.69% in 2025, its largest moves.
• Tracing SANA's Net Equity Issued and Repurchased over 4 years: stood at $1.2 million in 2022, then surged by 1935.56% to $24.1 million in 2023, then sank by 100.12% to -$29000.0 in 2024, then jumped by 58720.69% to $17.0 million in 2025.
• Business Quant data shows SANA's Net Equity Issued and Repurchased at $17.0 million in Q4 2025, $28.6 million in Q3 2025, and $500000.0 in Q2 2025.